Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development.

Xing HuangTianyu TangGang ZhangTingbo Liang

Published in: Molecular cancer (2021)

CD247, FCGR1A, and TRRAP are potential antigens for mRNA vaccine development against cholangiocarcinoma, specifically for patients with IS2 tumors. Therefore, this study provides a theoretical basis for the anti-cholangiocarcinoma mRNA vaccine and defines suitable patients for vaccination.

Keyphrases

end stage renal disease
ejection fraction
binding protein
newly diagnosed
chronic kidney disease
dendritic cells
prognostic factors
peritoneal dialysis
climate change
human health
risk assessment
patient reported
nk cells